gaining confidence in predicting and assessing response to cancer immunotherapies
Published 1 year ago • 504 plays • Length 56:08Download video MP4
Download video MP3
Similar videos
-
1:11:32
refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
49:36
pathway to decoding the impact of cancer immunotherapy
-
1:31:16
pathologic response after neoadjuvant immunotherapy: facilitating progress in early-stage cancers
-
3:17
multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer
-
1:29:21
the central role of biomarker testing in piecing together the immuno-oncology puzzle
-
0:39
predicting immunotherapy response in bladder cancer
-
55:16
targeting tigit to extend immunotherapy benefits to more cancer patients
-
13:36
andrew allen, gritstone oncology on cancer neoantigen vaccines
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
1:21
how can we improve responses to immunotherapy in patients with bladder cancer?
-
26:32
standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
-
25:23
targeting tumor mutations for personalized cancer immunotherapy
-
10:46
cancer immunotherapy workshop 2021 – introduction to imaging applications in immuno-oncology
-
17:30
immunotherapy in lung cancer: panacea vs. reality?
-
59:18
optimizing novel her2-targeted therapies and other agents in gastric cancer care
-
3:39
foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy
-
1:03:49
making the most of the new era of immuno-oncology in tnbc: essential guidance for surgeons